Utpal Koppikar

Director/Board Member bij C4 THERAPEUTICS, INC.

Vermogen: 172 592 $ op 31-03-2024

53 jaar

Health Technology

Consumer Services

Actieve functies van Utpal Koppikar

Bedrijven	Functie	Begin	Einde
C4 THERAPEUTICS, INC.	Director/Board Member	16-03-2022	-
C4 THERAPEUTICS, INC.	Independent Dir/Board Member	16-03-2022	-

Bedrijven	Functie	Begin	Einde
ATARA BIOTHERAPEUTICS, INC.	Director of Finance/CFO	07-06-2018	31-03-2023
FLEXION THERAPEUTICS, INC.	Director/Board Member	09-07-2021	19-11-2021
GILEAD SCIENCES, INC.	Corporate Officer/Principal	01-02-2017	01-06-2018

Stanford University	Graduate Degree
University of Maryland	Undergraduate Degree
UCLA Anderson School of Management	Masters Business Admin

Internationaal

Verenigde Staten

Operationeel

Sectoraal

Health Technology	5
Consumer Services	4

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	1
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.	Health Technology

Bedrijven in privébezit

Health Technology